Global Registry
A4D-Ab
Zeripatamig
A4DAB307
|
Phase-I
Target
IAP/CD47;CD19
Isotype / Subclass
G1;G1 / None
Company
TG Therapeutics
Clinical Status
Phase-I
Format
Bispecific mAb
Synonyms
TG-1801
TG1801
TG 1801
pH Formulation
—
IMGT
PubChem (442064691)
PubChem (471299000)
PubChem (472423077)
Thera-SAbDab
YAbS
Avg A4D Score
-0.69
Score Range
-0.69 to -0.69
Structures
2
Show Structure Profiles
Avg. A4D Score per Structure
pH at Min / Max Aggregation Propensity
Associated Structural Profiles
Level 2
Export CSV
Column Filters
Min Seq. Identity (%)
0
Min Avg A4D Score
-5.0
Max Avg A4D Score
2.0
Min pH (min agg. prop.)
0.0
Max pH (max agg. prop.)
14.0
Reset Filters
Structure ID
Source PDB
Seq. Identity
Avg. A4D Score
pH (Min Agg.)
pH (Max Agg.)
Score CDR
Score non-CDR
A4DAB307_8rp8_H_L
8rp8
99%
-0.6933
6.5
9.0
-0.3547
-0.7324
A4DAB307_8rp8_A_B
8rp8
99%
-0.6866
6.5
4.0
-0.3333
-0.7273